Care Plan for High Cholesterol in Patients Over 75 Years of Age

Assessment and Risk Stratification

For patients over 75 years with clinical atherosclerotic cardiovascular disease (ASCVD), the American College of Cardiology recommends continuing moderate or high-intensity statin therapy after evaluating potential benefits, adverse effects, drug interactions, frailty, and patient preferences 1
For primary prevention in adults over 75 years without established ASCVD, the Mayo Clinic recommends initiating statin therapy with a weaker recommendation (Class IIb) due to limited and conflicting evidence 2

The American College of Cardiology recommends continuing the current statin regimen in patients over 75 years with clinical ASCVD who are tolerating statin therapy 1
For those not currently on statin therapy but with established ASCVD, the American College of Cardiology recommends initiating moderate-intensity statin therapy after evaluating potential benefits, adverse effects, drug interactions, frailty, and patient preferences 1
High-intensity statin therapy may be considered in select patients with recent ASCVD events and low risk of adverse effects, according to the American College of Cardiology 1

The American Diabetes Association recommends considering moderate-intensity statin therapy in patients with diabetes mellitus and additional cardiovascular risk factors 3
For those with very high LDL-C levels, the American College of Physicians recommends considering statin therapy after careful evaluation of risk-benefit ratio 4

The American Diabetes Association recommends lifestyle modifications for all patients, including dietary changes, increased consumption of omega-3 fatty acids, viscous fiber, and plant stanols/sterols, weight management, and regular physical activity appropriate for age and functional status 5
For patients with elevated triglycerides, the American College of Cardiology recommends intensifying lifestyle therapy and optimizing management of secondary factors 6

The American College of Cardiology recommends assessing for polypharmacy and potential drug interactions before initiating or continuing lipid-lowering therapy 1
The National Kidney Foundation recommends evaluating renal function, as some statins require dose adjustment with decreased renal function 7
The American College of Cardiology recommends monitoring for statin-associated side effects, which may be more common or problematic in older adults 1

The American Diabetes Association recommends regular lipid profile monitoring (every 1-2 years) for ongoing assessment 5
The American College of Cardiology recommends evaluating for medication adherence, side effects, and changes in overall health status at follow-up visits 1
The Mayo Clinic recommends reassessing cardiovascular risk periodically, as risk factors may change with advancing age 2

The National Kidney Foundation recommends avoiding initiating statin therapy in patients on dialysis, as evidence does not support benefit in this population 7
The Mayo Clinic recommends recognizing that the benefit-to-risk ratio of statin therapy decreases with advancing age and increasing frailty 2